For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News
Pharma News: Biotech giant Gilead Sciences, once hailed for its pharmaceutical advancements, is now in the spotlight for a different reason: significant layoffs and office closures. Known globally for its contributions to HIV treatment and its controversial COVID-19 drug, Remdesivir, the California-based company has announced plans to cut over 100 positions at its Foster City headquarters.
Gilea...
Pharma News: Introduction to Tirzepatide and its Groundbreaking Study
In an impressive three-year study, pharmaceutical giant Eli Lilly presented data that highlights tirzepatide's remarkable potential in preventing Type 2 diabetes among prediabetic individuals. This Indianapolis-based company has conducted extensive research on tirzepatide, a dual GIP/GLP-1 receptor agonist, which has shown ...
Pharma News: SIGA Technologies, a pharmaceutical company known for its antiviral treatments, has recently encountered a significant setback that has shaken investor confidence and caused the company’s shares to plummet. The Mpox therapy, which the company had invested substantial resources and hopes in, failed to meet clinical expectations. In a dramatic development, SIGA has also announced ...
Pharma News: Regeneron Pharmaceuticals has achieved a significant milestone with the European Commission's approval of its bispecific antibody drug, Ordspono (odronextamab), for the treatment of two types of lymphoma. This approval marks a crucial step for the company, especially after facing rejection from the U.S. Food and Drug Administration (FDA). The European Commission's decision now...
Pharma News: In a significant development affecting the Indian pharmaceutical market, French multinational pharma giant Sanofi has announced the voluntary recall of two popular children's medications - Allegra Suspension (Fexofenadine Hydrochloride Suspension) and Combiflam Suspension (Ibuprofen and Paracetamol Suspension). The recall has been initiated as a precautionary measure due to concer...
Pharma News: A New Dawn for Alzheimer's Treatment
In the relentless pursuit of breakthroughs in Alzheimer's disease treatment, Asceneuron, a Swiss biotechnology company, has made significant strides. The company recently announced the successful completion of a US$100 million Series C funding round, spearheaded by Novo Holdings. This financial boost is set to propel Asceneuron's innov...
Pharma News: The US Food and Drug Administration (FDA) has granted approval for Amgen’s BLINCYTO (blinatumomab) to treat CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in patients aged over one month. This approval is significant for both adult and pediatric patients in the consolidation phase of their treatment.
New U.S. FDA Appro...
Pharma News: Despite all the controversies regarding the COVID-19 vaccines and the new mRNA technology, Moderna has received the U.S. FDA approval for its latest vaccine, mRESVIA, designed to protect older adults from respiratory syncytial virus (RSV). The pharma giant claims that this approval marks a critical milestone for the biotech company, showcasing its mRNA technology's versatility and...
Pharma News: Duchenne muscular dystrophy (DMD) is a devastating genetic disorder characterized by progressive muscle degeneration and weakness. It primarily affects boys, typically diagnosed in early childhood, and leads to mobility challenges, respiratory complications, and a shortened lifespan. With limited treatment options available, DMD represents a significant unmet medical need, spurring in...
Pharma News: In recent years, Pfizer, one of the world's largest pharmaceutical companies that is primarily of American origins, has found itself entangled in a legal battle concerning its popular heartburn drug, Zantac. The company has agreed to settle more than 10,000 lawsuits related to allegations that it concealed the cancer risks associated with Zantac. This development that is covered i...
Pharma News: In the realm of drug development and regulatory approval, the decision-making process is often complex, balancing the urgent need for effective treatments with the necessity of robust clinical evidence. One recent case that has sparked significant discussion and scrutiny is the U.S. Food and Drug Administration’s (FDA) accelerated approval of Elevidys, a gene therapy developed b...
Pharma News: In the realm of medical breakthroughs and pharmaceutical advancements, the synergy between research entities and manufacturing powerhouses often heralds new eras of treatment accessibility and efficacy. The recent partnership between ImmunityBio and the Serum Institute of India stands as a prime example of such collaboration. This new alliance aims to tackle the longstanding monopoly ...
Pharma News: In recent news, Dr. Reddy's Laboratories Ltd, a leading pharmaceutical company, has taken the proactive step of initiating a voluntary recall of six lots of Sapropterin Dihydrochloride powder for oral solution 100 mg in the US market. This recall, driven by concerns over potential potency issues, has significant implications for patients relying on this medication to manage hyperp...
Pharma News: The U.S. Food and Drug Administration's (FDA) accelerated approval program has long been hailed as a crucial pathway for providing early access to potentially life-saving drugs, particularly in the realm of cancer treatment. Established in 1992 initially to address the urgent need for HIV/AIDS medications, this program allows for expedited approval of drugs that show promising ini...
Pharma News: In a significant development within the pharmaceutical industry, Moderna, a pioneering biotechnology company known for its controversial COVID-19 mRNA-based vaccines, has secured a substantial financial boost from Blackstone Life Sciences. The investment, amounting to US$750 million, is aimed at advancing Moderna's influenza (flu) vaccine program, marking a strategic collaboration...
Med News: In recent years, the commonly prescribed anxiety drug pregabalin has come under scrutiny due to a significant increase in linked fatalities. This surge in deaths, which more than doubled from 187 in 2018 to 441 in 2022 in England and Wales, has sparked concerns about the safety of this medication.
Death registrations related to Gabapentin or Pregabalin, England and Wales: 2018 and 2022 ...
Pharma News: In a surprising turn of events, pharmaceutical giant Pfizer recently announced the abrupt halt of the US$350 million Seagen plant construction project, a mere three months after completing the $43 billion acquisition of Seagen in December. This unforeseen decision has left 120 workers' roles hanging in the balance, while industry analysts speculate that Pfizer may face a potential...
Pharma News: In a disconcerting turn of events, the pharmaceutical industry in Himachal Pradesh, India, is facing intense scrutiny as 374 medicine samples from companies located in the Baddi-Barotiwala and Nalagarh areas have failed quality tests in the past year. The revelation came to light during the Question Hour session in the Assembly House, raising concerns among various Members of the Legi...
Pharma News: Daiichi Sankyo, a prominent pharmaceutical company, finds itself entangled in a web of regulatory violations and reprimands from the U.K.'s Prescription Medicines Code of Practice Authority (PMCPA). The allegations revolve around the marketing communications pertaining to Daiichi's cholesterol-lowering drugs, Nilemdo and Nustendi. Despite vehemently denying any wrongdoing, the...
Pharma News: In recent pharmaceutical news, the European Medicines Agency (EMA) has issued a series of approvals and positive recommendations for several groundbreaking drugs, showcasing the relentless efforts of the pharmaceutical industry in advancing treatments for various medical conditions. Among the notable approvals are Travere Therapeutics' Filspari for IgA nephropathy, Johnson & J...
Pharma News: In the ever-evolving landscape of pharmaceutical litigation, Gilead Sciences has found itself embroiled in a protracted legal battle over its Tenofovir Disoproxil Fumarate (TDF)-based HIV drugs. The core of the dispute revolves around allegations of negligence, an unconventional approach where the focus is not on the inherent defects of the drug but on the purported delay in developin...
Pharma News: In an unexpected and controversial move, pharmaceutical behemoth Pfizer has plunged into the realm of oncology with the acquisition of Seagen, a small drug company specializing in the treatment of "turbo cancers."
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-seagen
This staggering US$43 billion deal has left many p...
Pharma News: In a groundbreaking move that signals a paradigm shift in the global biopharmaceutical manufacturing landscape, Novo Nordisk, the eminent player in GLP-1 diabetes and weight-loss drugs, is aggressively expanding its footprint in Ireland.
The recent acquisition of an Alkermes pill factory in Athlone and the submission of a planning application for an expansive manufacturin...
Pharma News: India is a country where doctors and researchers can be easily bought for small sums of monies to manipulate studies and officials at regulatory agencies in India can be easily bribed to issue relevant drug and supplement approvals or licenses despite ‘half-baked’ supporting data. Worse, the various companies in India that are known to manufacture various generic drugs, su...
Pharma News: In a groundbreaking move to address the escalating global threat of antimicrobial resistance (AMR), LimmaTech Biologics has secured exclusive clinical development rights from AbVacc for the revolutionary multivalent toxoid vaccine candidate, LBT-SA7 (formerly IBT-V02), designed to combat infections caused by the notorious bacterial pathogen, Staphylococcus aureus (S. aureus). This str...
Pharma News: In a significant step forward for public health, Sanofi has announced a groundbreaking agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, to develop and commercialize a potential first-in-class vaccine targeting extraintestinal pathogenic Escherichia coli (ExPEC). This innovative vaccine, currently in Phase 3 clinical trials, aims to combat ExPEC's deva...
Thailand Medical News Team Aug 29, 2023 1 year ago
Pharma News: In a significant breakthrough for the treatment of lower-risk myelodysplastic syndromes (MDS), the U.S. Food and Drug Administration (FDA) has granted approval for Reblozyl® (luspatercept-aamt), developed by Bristol Myers Squibb. This approval marks a turning point in addressing chronic anemia in adult patients with very low- to intermediate-risk MDS who may require regular red bl...
Thailand Medical News Team Aug 18, 2023 1 year ago
Pharma News: The rapid pace of innovation in the pharmaceutical industry has led to the frequent launch of new cancer drugs, promising hope for patients battling this formidable disease. However, a concerning trend has emerged, revealing that many of these drugs receive approval before substantial evidence of their long-term effectiveness can be established. In an era where resources are finite an...
Thailand Medical News Team Aug 17, 2023 1 year ago
Pharma News: A lawsuit has been filed against pharmaceutical giants Novo Nordisk and Eli Lilly, makers of the widely used type 2 diabetes drugs Ozempic and Mounjaro. The lawsuit claims that these medications, which are also prescribed off-label for weight loss, have caused severe stomach problems in patients, including a condition known as gastroparesis, or stomach paralysis.
The Laws...
Thailand Medical News Team Aug 09, 2023 1 year ago
Pharma News: In a groundbreaking development, Novo Nordisk's revolutionary weight loss drug, Wegovy, has not only captured the attention of the weight-conscious population but has now demonstrated a remarkable potential to significantly lower the risk of major cardiovascular events (MACE).
The results of an extensive clinical trial have unveiled a 20% reduction in the occurrence o...
Thailand Medical News Team Aug 09, 2023 1 year ago
Pharma News: You've probably seen the unsettling commercial that warns that the virus responsible for shingles might already be lurking within you if you had chickenpox as a child. This chilling message serves as a reminder for people to consider getting the shingles vaccine. But, alas, the vaccine doesn't provide foolproof protection against shingles; it simply helps mitigate the symptoms...
Thailand Medical News Team Aug 07, 2023 1 year ago
Pharma News: According to data from the pharma industry, the global market for pulmonary arterial hypertension (PAH) treatments is on track to reach nearly US$11 billion by 2030, making PAH drugs highly sought-after assets in the biopharmaceutical industry. While the projected figures for other markets, such as non-alcoholic steatohepatitis and obesity, may be more substantial, the unique appeal o...
Pharma News - diclofenac - UGT2B17 May 01, 2023 2 years ago
Pharma News: New research has unveiled the potential reason behind the alarming side effects of a widely-used painkiller, diclofenac, putting millions of people at risk for severe complications. A misunderstood enzyme responsible for metabolizing the drug may be the key factor leading to serious health consequences, including heart damage.
In a groundbreaking study, scientists have discovered a s...
COVID-19 News - SARS-CoV-2 Altered Blood-Brain Barrier - Drug Transport Apr 01, 2023 2 years ago
COVID-19 News: A new study by Mexican medical scientists has found that SARS-CoV-2 virus is able to alter the Blood-Brain Barrier of the human host with concerning implications as many of the drugs used during treatment can also thereafter gain access to the brain when in the first place, during development and research, they were made knowing very well that their active molecules would never be a...
Pharma News -Nitroglycerin Spray Shortage Mar 22, 2023 2 years ago
Pharma News: Shortage Of Nitroglycerin Spray, A Heart Medication In Canada Is Expected to Extend To The America and Europe Due To Raw Materials Crisis.
Pharma News: A shortage of a critical heart medication, nitroglycerin spray, has sparked concerns among patients and healthcare providers in Canada, particularly in Alberta.
The fast-acting nitroglycerin spray is used by spraying on...
U.S. Medical News - Pfizer Recalls Nurtec ODT Migraine Tablets Mar 19, 2023 2 years ago
U.S. Medical News: Pfizer has initiated the withdrawal of millions of Nurtec ODT Migraine tablet packs in the United States due to the lack of necessary child-resistant blister packs, which, according to U.S. regulators, present a poisoning hazard to children.
In all, more than four million blister packs of Pfizer’s prescription migraine drug Nurtec ODT is being recalled in Amer...
Medical Warnings - Online Influencers Mar 14, 2023 2 years ago
Medical Warnings: A new study led by researchers from University of Colorado-USA has found that many online “Patient Influencers” are being paid by pharmaceutical companies to mislead viewers on prescription drugs!
In some cases, these online medical influencers are not just previous patients but also doctors, researchers and so called “experts’ and even advocacy o...
Pharma News -Silver Nanoparticles - Antivirals - COVID-19 - H5N1 Mar 13, 2023 2 years ago
Pharma News: The ongoing COVID-19 pandemic with the emergence of new variants and sub-lineages have made identifying effective treatments become even more challenging.
Unknown to many, drug resistance has developed in many of these new sub-lineages not only with the used of officially approved antivirals such as remdesivir, paxlovid, molnupiravir, favipiravir but even with drugs unofficially an...
Pharma News: Apotex, Canada's largest generic drug maker, has announced a recall of six batches of the glaucoma and ocular hypertension drug brimonidine tartrate ophthalmic solution due to sterility concerns.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-brimonidine-tartrate-ophthalmic-solution-015-due
The company is...
Pharma News - Sandoz Dicillin Feb 24, 2023 2 years ago
Pharma News: The Danish Medicines Agency has initiated a recall of Sandoz’s Dicillin antibiotics after it was discovered that the drugs were contaminated and lead to users developing an infection involving Carbapenemase-Producing ST79 Enterobacter Hormaechei.
https://laegemiddelstyrelsen.dk/da/nyheder/2023/antibiotikalaegemidlet-dicillin-fra-firmaet-sandoz-tilbagekaldes/
The recall ...
Pharma News - Ibuprofen - Naproxen Nov 25, 2022 2 years ago
Pharma News: A new study lead by researchers from the Department of Radiology and Biomedical Imaging at the University of California, San Francisco- USA have found that the usage of pain relievers like Ibuprofen and Naproxen actually worsens arthritis inflammation.
The study team warns that the use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are see...
Pharma News: A new study by Italian researchers has shockingly found that Nirmatrelvir which is a key component of the drug Paxlovid that is being peddled by American and British medical ‘experts’ to treat COVID-19 actually blunts the development of antiviral adaptive immune responses in mice infected with SARS-CoV-2!
According to the study team, this might help explain the vi...
Source: Pharma News - Gepotidacin - UTIs Nov 05, 2022 2 years ago
Pharma News: Pharma giant, GSK has developed a new antibiotic called Gepotidacin that could fight tough-to-treat drug resistance urinary tract infections (UTIs).
Phase 3 clinical trials proved to not only be successful but demonstrated the efficacy of the drug beyond the researchers’ expectations that the trials ended earlier than expected.
https://www.gsk.com/en-gb/media/press-rele...
Pharma News: Florida based AzurRx BioPharma, a company specializing in the development of non-systemic therapies for gastrointestinal (GI) diseases has announced that it has signed an exclusive worldwide licensing agreement with First Wave Bio, Inc for the use of their patented and proprietary oral and rectal formulations of niclosamide for the treatment of immune checkpoint inhibitor-as...
Pharma News: Pharma giant Roche has partnered with Regeneron Pharmaceuticals to develop, manufacture and distribute Regeneron’s antiviral antibody combination, REGN-COV2, as a potential treatment of COVID-19.
The new antibody combination REGN-COV2 could help treat patients with symptoms and also prevent the disease in individuals exposed to the SARS-CoV-2 coronavirus.
An init...
Pharma News: One of the world’s biggest pharma giant Novartis, in a PR move publicly announced the launch an initiative to assist patients in low-income and lower-middle-income countries in getting access to affordable drugs for COVID-19.
The pharma company said that they are specifically making 15 drugs from its Sandoz division available that can be used to treat symptoms...
Source: Thailand Medical News Jan 18, 2020 5 years ago
Sales figures for the first cannabis-based medicine in the United States are in and they’re telling a bullish story, according to GW Pharmaceuticals CEO Justin Gover.
The drug, Epidiolex, which contains cannabidiol to treat severe forms of epilepsy, brought in $104 million in net sales in the fourth quarter and a total of $296 million in 2019 across the globe, the British pharma...
Source: Thailand Medical News Jan 17, 2020 5 years ago
The pharmaceutical news and media segment is abuzzed about a new development that will disrupt the way that individuals with allergies or reactions having anaphylaxis episodes are treated or able to treat themselves. A privately held Raleigh medical device company called Bryn Pharma, is on track to soon provide people who have severe, possibly life-threatening allergies a needle-free option t...
Source: Thailand Medical News Jan 08, 2020 5 years ago
Galen Pharma, a Northern Ireland-based, globally focused pharmaceutical sales and marketing firm has acquired Swedish-headquartered POA Pharma in a multi-million pound takeover agreement.
This takeover allows Galen to expand its global footprint further into Scandinavia and Northern Europe. POA Pharma has offices and facilities in Denmark, Sweden, Norway and Finland.
The buy out will also broad...
Source: Thailand Medical News Jan 06, 2020 5 years ago
Pharma giant, Merck also known as MSD outside the United States and Canada, has announced an exclusive worldwide research collaboration and license agreement with Taiho Pharmaceutical Co, Ltd., (“Taiho”) and Astex Pharmaceuticals (UK), a wholly owned subsidiary of Otsuka Pharmaceutical Co., Ltd. (“Astex”), focused on the development of small molecule inhibitors agains...
Source: Thailand Medical News Dec 26, 2019 5 years ago
Pharma Industry News
Roche and Sarepta have signed a legal deal providing Roche exclusive commercial rights to SRP-9001 (AAVrh74.MHCK7.micro-dystrophin), Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD), outside the United States.
Under the terms of the deal, Sarepta will receive US$1.15 billion in an upfront payment and an equity investment; up to $1.7 billion ...
Source: Thailand Medical News Dec 21, 2019 5 years ago
Novartis, the Swiss pharmaceutical company is preparing to give away 100 doses of the world's most expensive drug, which treats a rare childhood disorder, through a special recipient selection process.
The pharmaceutical giant announced this week that starting next month, its AveXis unit will begin distributing doses of Zolgensma, a one-time gene treatment for spinal muscular atrophy, also ...
Source: Thailand Medical news Dec 17, 2019 5 years ago
Pharmaceuticals giant Roche said it had received the necessary approval from competition authorities to acquire US gene-therapy group Spark, after the two companies reached a multibillion-dollar deal earlier this year.
Incorporated in 2013, Spark Therapeutics specialises in a new and growing segment of medicine for genetic diseases such as blindness, haemophilia, and neurodegenerative...
Source: Thailand Medical News Dec 11, 2019 5 years ago
It was announced that AstraZeneca will partner with DeepMatter to improve the productivity and reproducibility of compound synthesis by combining the pharma giant’s automated compound synthesis platform with DeepMatter’s DigitalGlassware™ data collection and structuring technology, through a collaboration whose value was not disclosed.
Glasgow based DeepMatter,is a big data and ...
Source: Thailand Medical Newss Dec 11, 2019 5 years ago
Pharma giant Roche has announced that it is terminating its precision medicine partnership with software developer Syapse later this month, the pharmaceutical and diagnostics giant confirmed Friday. The deal will end Dec. 18, less than two years after it began, a company spokesperson said.
Roche spokesperson Patrick Barth told Thailand Medical News, "As partnerships evolve, prioritie...